40,998 views | 01:30:12
There is a revolution underway in the world of medicine. As researchers identify the genetic variants responsible for cancer, schizophrenia and diabetes, and doctors tailor medications and diagnostic tests specifically for your genomic makeup, we inch closer to personalized medicine. But what does this mean for you today? And how will it impact your health care 10, 20 or 30 years in the future? ABC’s Richard Besser joins Francis Collins, George Church and Robert C. Green. They look over the leading edge of genomics research to learn the promise, pitfalls, and realities barreling toward us.
Robert C. Green is a medical geneticist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes at Brigham and Women’s Hospital and Harvard Medical School. He has been continuously funded by NIH for over 26 years and has published over 300 scientific articles.Read More
George Church is professor of genetics at Harvard Medical School and director of PersonalGenomes.org, providing the world’s only open-access information on human Genomic, Environmental, and Trait data (GET). His 1984 Harvard Ph.D. included the first methods for direct genome sequencing, molecular multiplexing, and barcoding.Read More